It stabilizes p53 protein and induces cell cycle arrest and apoptosis in follicular lymphoma cells that retain wild-type p53. When administered orally to the animals, MI-319 showed significant anti-lymphoma activity. The gene discussed is TP53; the disease is lymphoma.